drugset / Trial / NCT00047671

Ethnic Variations in Antidepressant Response

NCT00047671

Phase 4 Completed 400 enrolled National Institute of Mental Health (NIMH)
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This 11-week study aims to determine how genetic factors affect the way African Americans and Caucasians with major depression respond to antidepressant medication \[citalopram (Celexa®)\].

Timeline

Start
2002-06
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule

Indications